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Abstract
The contribution of inflammation to deleterious aging outcomes is increasingly recognized; however, little is known about
the complex relationship between interleukin-6 (IL-6) and brain structure, or how this association might change with
increasing age. We examined the association between IL-6, white matter integrity, and cognition in 151 community
dwelling older adults, and tested whether age moderated these associations. Blood levels of IL-6 and vascular risk (e.g.,
homocysteine), as well as health history information, were collected. Processing speed assessments were administered to
assess cognitive functioning, and we employed tract-based spatial statistics to examine whole brain white matter and
regions of interest. Given the association between inflammation, vascular risk, and corpus callosum (CC) integrity, fractional
anisotropy (FA) of the genu, body, and splenium represented our primary dependent variables. Whole brain analysis
revealed an inverse association between IL-6 and CC fractional anisotropy. Subsequent ROI linear regression and ridge
regression analyses indicated that the magnitude of this effect increased with age; thus, older individuals with higher IL-6
levels displayed lower white matter integrity. Finally, higher IL-6 levels were related to worse processing speed; this
association was moderated by age, and was not fully accounted for by CC volume. This study highlights that at older ages,
the association between higher IL-6 levels and lower white matter integrity is more pronounced; furthermore, it underscores
the important, albeit burgeoning role of inflammatory processes in cognitive aging trajectories.
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Introduction
Aging is associated with myriad cognitive and structural brain
changes that were once assumed to be immutable processes;
however, current conceptualizations underscore the contribution
of modifiable risk factors [1,2], with increasing emphasis on the
role of the immune system in aging outcomes [3,4]. While
numerous associations have been found between inflammation
and neurodegenerative disease [5], less is known about how
inflammatory mediators might relate to the cognitive neuroscience
of aging.
Although the pro-inflammatory cascade involves numerous
mediators, interleukin-6 (IL-6) represents one of the more widely
researched inflammatory factors. IL-6 is released by peripheral
and central nervous system cells, including adipose tissue, glia, and
neurons, and is expressed at low levels in healthy adults.
Circulating blood levels of IL-6 increase with age [6] and may
have negative effects if elevated for a sustained period. Specifically,
IL-6 is strongly associated with a spectrum of vascular-mediated
diseases (e.g. cardiovascular disease, atherosclerosis) [7] that
increase vulnerability to cerebrovascular events [8] and may
hasten cognitive decline in older adults [9]. An important
consideration, however, is how IL-6 levels might relate to specific
brain tissue and whether the strength of this association increases
with age. Inflammation more broadly induces changes in vascular
permeability [10] and myelin morphology [11], both of which may
contribute to alterations in white matter integrity. In accord with
these proposed mechanisms, recent studies have demonstrated
that higher levels of inflammation are related to reduced fractional
anisotropy (FA) in white matter tracts of healthy elders [11],
particularly in the corpus callosum [12,13]. No studies to date,
however, have examined factors that might account for the
relation between IL-6 levels and white matter integrity, nor have
prior investigations clarified how this association might change
with increasing age. This is particularly important given the
significant remodeling of the immune system in older adults [14],
PLOS ONE | www.plosone.org 1 September 2014 | Volume 9 | Issue 9 | e106521
as the link between IL-6 levels and brain structure may become
more prominent over time.
The current study addresses pressing gaps in the literature by
examining the relation between IL-6 levels and white matter
integrity, and assessing whether it is a) moderated by age and b)
independent of traditional vascular risk factors and blood markers.
Considering the association between corpus callosum (CC)
integrity and aging [15], vascular risk factors [16], and inflamma-
tion [12,13,17], we chose the CC as our primary region of interest.
However, in order to assess the possibility of more extensive white
matter alterations, we also examined whole brain associations with
IL-6. We hypothesized that mean levels of CC integrity would be
lower among subjects with higher IL-6 levels than among subjects
with lower IL-6, and magnitudes of this association would increase
with age. We also assessed whether higher IL-6 levels were related
to a cognitive index strongly linked with white matter integrity in
older adults (i.e. information processing speed) [18], thereby
solidifying a connection between IL-6 and both structure and
behavior. We predicted that higher levels of IL-6 would be
associated with slower processing speed.
Methods
Participants (Table 1)
A sample of 152 healthy, community dwelling older adult
participants was selected from the University of California, San
Francisco Memory and Aging Center database based on the
availability of plasma blood markers of interleukin-6 (IL-6) as well
as diffusion tensor imaging. Both evaluations occurred within a 90-
day period. Participants were recruited from our larger NIH Aging
and Cognition study (ages 62–90), and were reviewed in a
screening visit, which entailed an informant interview, neurolog-
ical examination, and cognitive testing. Inclusion as a ‘‘healthy’’
participant was based on several criteria, including a Mini-Mental
State Exam score of $26, Clinical Dementia Rating score of 0,
and no subject or informant report of cognitive decline during the
previous year. Participants were excluded if they had a major
psychiatric disorder, neurological condition affecting cognition
(e.g. large vessel infarct), dementia or mild cognitive impairment,
substance abuse, systemic medical illnesses (e.g. cancer), current
medications likely to affect CNS functions, or current depression
(Geriatric Depression Scale Score .15/30) [19]. Notably, one
individual’s data was removed (see Laboratory Measures section
below) due to concerns of underlying illness (n = 151). The study
was approved by the UCSF committee on human research, and all
subjects provided written, IRB-approved informed consent before
participating. In compliance with data sharing plans, both
summary data (Table 1; Figure 1; Figure 2) and raw data
(Figure 3 scatterplot) are provided in the manuscript.
Measures
Body Mass and Vascular Risk. Body mass index (BMI) was
calculated as follows: [weight (kg)/height (m)2], and analyzed as a
continuous variable. All available information regarding medical
and health history was garnered via participant self-report. Health
variables included lifetime history (yes/no) of the following:
smoking, hypertension, hypercholesterolemia, and diabetes.
Laboratory Measures. All participants were queried re-
garding recent illnesses in the past week (e.g. influenza, respiratory
infection, etc). One individual’s data was subsequently removed
from all analyses due to concerns that they may have had an acute
underlying illness. Fasting blood was collected into serum
Table 1. Participant Characteristics, Laboratory Markers, and Neuroimaging Indices.
N Mean (SD) Range
Demographics/Clinical Characteristics:
Age (Years) 151 71.6 (5.7) 62–87
Gender (% Female) 151 57.0
Education (Years) 151 17.5 (2.1) 11–22
GDS (Total Score) 142 2.7 (2.9) 0–15
Homocysteine (umol/L) 150 8.3 (3.5) 2.4–30.5
IL-6 (pg/ml) 151 1.8 (1.7) 0.0–9.1
Body Mass Index 136 25.4 (3.7) 18.0–37.2
History of Hypertension (%) 143 39.4
History of Smoking (%) 144 51.0
History of Hypercholesterolemia (%) 144 50.7
Diabetes (%) 144 4.2
Structural and Diffusion Imaging:
Corpus Callosum (Total Volume) 144 2867.39 (403.44) 1831.00–3989.00
Corpus Callosum (Mean FA) 151 0.63 (0.03) 0.53–0.70
Splenium 0.71 (0.03) 0.63–0.77
Body 0.61 (0.04) 0.51–0.69
Genu 0.57 (0.04) 0.45–0.65
Cognitive Evaluation:
MMSE (Total Score) 151 29.4 (0.9) 26.0–30.0
Processing Speed (Composite Score) 150 1.5 (1.4) 20.2–8.7
Abbreviations: GDS =Geriatric Depression Scale; IL-6 = interleukin-6; FA = fractional anisotropy.
doi:10.1371/journal.pone.0106521.t001
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separator tubes between 8:00 am and 10:00 a.m. for all partici-
pants, and left to clot at room temperature for 30–60 min, and
into EDTA plasma tubes. The blood was then centrifuged at
2500 rpm (1300–1800) at room temperature for 15 min. Plasma
and serum were stored at 280uC until analysis. IL-6 was
measured using a Quantikine ELISA kit from R&D systems
(Minneapolis, MN). Homocysteine, an independent risk factor for
vascular disease [20], was measured by HPLC with post-column
fluorescence detection [21]. IL-6 and homocysteine were mea-
sured in the research laboratory of Dr. Ralph Green at the
University of California Davis Medical Center (Sacramento, CA).
Neuroimaging. MRI scans were obtained within 3 months
of the participants’ blood draw. Scans were conducted on a 3.0
Tesla Siemens (Siemens, Iselin, NJ) TIM Trio scanner equipped
with a 12-channel head coil located at the UCSF Neuroscience
Imaging Center. Whole brain images were acquired using
volumetric magnetization prepared rapid gradient-echo sequence
(MPRAGE; TR/TE/TI= 2300/2.98/900 ms, a=9u). The field
of view was 2406256 mm, with 161 mm in-plane resolution and
1 mm slice thickness. Diffusion imaging data were acquired via a
spin-echo, echo planar imaging sequence with 55 slices 2 mm
thick (TR/TE=8000/109 ms, FOV=220 mm, ma-
trix = 1006100) in two series. One series contained diffusion
gradients and 64 diffusion directions (b = 0 and b=2000 s/mm2, 1
average) while the other had no diffusion gradients and 6 diffusion
directions (b = 0, 10 averages).
FreeSurfer: The T1 MPRAGE structural MR images were
analyzed using the FreeSurfer image analysis suite, which is
documented and freely available for download online at: http://
surfer.nmr.mgh.harvard.edu. FreeSurfer is a surface-based struc-
tural MRI analysis tool that segments white matter and tessellates
both gray and white matter surfaces [22]. Previous publications
have provided detailed descriptions and validation of the software
[23,24]. After initial automated segmentation through FreeSurfer
version 5.1, each subject’s image was individually checked for
quality and accuracy of segmentation. Inaccuracies in grey and
white matter segmentation, as well as inaccurate pial boundaries
and residual skull fragments were manually corrected with
FreeSurfer’s built-in editing software. These cases were then
reprocessed to take edits into account and final volumes were
recalculated. Intracranial volume (ICV) was calculated based on
FreeSurfer’s own eTIV (estimated total intracranial volume)
metric, which uses atlas normalization as well as the relationship
between the linear transform to MNI305 space and ICV.
Tract-Based Spatial Statistics: DTI data were eddy current
corrected using FMRIB’s Diffusion Toolbox (FSL 4.1.6; http://fsl.
fmrib.ox.ac.uk/fsl) [25]. Brain extraction and binary brain mask
creation took place using the b0 image through the FSL Brain
Extraction Tool. Fractional Anisotropy (FA) maps were created
Figure 1. Whole brain analysis of IL-6 levels and white matter integrity. Whole brain TBSS analysis displayed at p#01, using TFCE and
corrected for multiple comparisons. The figure shows white matter regions inversely associated with IL-6 levels, thereby displaying areas in which
higher IL-6 levels were associated with lower fractional anisotropy. Significant results were primarily restricted to the body and splenium, and extend
into the genu of the corpus callosum.
doi:10.1371/journal.pone.0106521.g001
Figure 2. Displays slopes for the association between IL-6 and white matter integrity in the genu, body, and splenium of the corpus
callosum across age (solid line) accompanied by 95% confidence intervals (dashed lines). IL-6 marginal effects are adjusted for
demographic variables and vascular factors/blood markers.
doi:10.1371/journal.pone.0106521.g002
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based on the diffusion tensor modeling results from FSL DTIFIT.
Whole brain white matter analysis was conducted using FSL’s
TBSS protocol [26]. All subjects’ FA data were registered using
the nonlinear registration tool FNIRT [27] to the IXI Aging DTI
Template [28] masked by a study-specific binary averaged image.
The mean FA and mean FA skeleton were created from the study
sample. Each subject’s aligned FA data was then projected onto
the mean FA skeleton and the resulting data fed into voxelwise
cross-subject statistics.
Cognitive Measures. Cognitive testing was obtained within
3 months of the participants’ blood draw and neuroimaging scan.
Considering the strong association between both aging and slower
processing speed [29], as well as lower fractional anisotropy and
slower processing speed [18,30], participants were administered a
series of processing speed tasks, and were asked to make rapid
judgments about stimuli presented on the laptop display. The tasks
have been validated in previous studies [31]. Briefly, the tasks
included the following: animal matching, word rhyming, word
judgment, and word pronunciation tasks. Animal matching
requires assessment of whether the word presented on a screen
is an animal or not; word rhyming requires evaluation of whether
two four-letter words presented on a screen rhyme; word judgment
necessitates assessment of whether the 3-letter stimuli presented
are real words versus non-words; finally, the word pronunciation
task requires the subject to choose which stimuli sounds like a real
word (e.g. ‘‘doon’’ vs ‘‘filt’’; correct answer is ‘‘doon’’ as it sounds
similar to the real word, ‘‘dune’’). For data reduction purposes, a
scaled response latency z-score was calculated for each task based
on the mean and standard deviation time among a sample of
young adult controls (n = 40; 17 males age 23.662.5 years). We
created a single mean z-score based on all tasks, with higher factor
scores reflecting slower information processing speed.
Statistical Analyses
Covariate Selection. Using correlation analyses, demo-
graphic and blood marker variables were identified as covariates
for statistical models if they were significantly associated with
either the predictor variable (IL-6) or primary region of interest
(ROI) (CC; p,.05). Age was mean centered at 71.6 years.
Whole Brain. We hypothesized an inverse association
between IL-6 and corpus callosum FA; however, given the
strikingly limited literature on this topic, we initially conducted a
whole brain analysis to ensure that additional regions strongly
associated with IL-6 levels were not excluded. Whole brain
statistical analyses were carried out using FSL’s Randomise, and
covariates included demographic variables. Results for this
analysis were considered significant if they survived Threshold-
Free Cluster Enhancement (TFCE) corrected at p#0.01 [32]. We
chose to employ the conservative p-value to minimize the number
of subsequent comparisons conducted, and further focus on areas
that displayed the most robust effects.
ROI. We employed the JHU ICBM-DTI-81 white matter
labels [33] to mask areas of the white matter skeleton,
corresponding to major white regions. We examined the genu,
body, and splenium of the CC as primary ROI’s. It is unclear
whether IL-6 levels associates with specific regions of the CC or
the entire interhemispheric tract; however, considering the
differential vulnerability of the CC to underlying neurodegener-
ative disease processes [34,35] and metabolic factors [16], we
chose to examine these sections individually. Notably, we elected
to include the entire ROI for each section of the CC rather than
extracting significant voxels from the whole brain analysis in order
to employ a more conservative analytic approach.
Mean FA values for each white matter region were calculated
from the white matter skeleton.
In addition, the combined volumes of the following FreeSurfer
regions were considered in exploratory analyses: Corpus Callosum
(CC) Posterior, CC Mid-Posterior, CC Central, CC Mid Anterior,
and CC Anterior.
Regression Analyses. We fit general linear models with age
and IL-6 as predictors, demographics and vascular risk factors/
blood markers as covariates, and an interaction term between age
and IL-6 as the primary variable of interest. CC ROI’s (separately)
served as the dependent variables. To quantify the marginal effect
of IL-6 in the presence of an interaction between age and IL-6, we
estimated this marginal effect of IL-6 as a function of both the
main effect and interaction terms on an equally spaced grid of age
values. Confidence intervals were based on standard error
estimates obtained using the delta method. This allowed us to
address whether the magnitudes of association between IL-6 and
white matter outcomes differed as a function of participant’s age.
Given that several of the independent variables are known to be
associated with each other [12], the corresponding regression
coefficients may be poorly determined and exhibit high variance
[36]. Ridge regression analyses are thought to provide protection
against potential inflation of variance in the estimates, thus
alleviating effects of multicollinearity [36]. We therefore conduct-
ed a follow-up ridge regression analysis in order to assess the
robustness of our conclusions.
Figure 3. Scatterplots display the association between IL-6 levels and white matter integrity, as a function of age tertiles (for
descriptive purposes). White matter fractional anisotropy variables (i.e. genu, body, splenium of the corpus callosum) were regressed over
covariates to create a residualized variable. Age was divided into tertiles; ‘0’ reflects the lowest ages in our sample (,67 years), ‘1’ reflects the middle
third of ages (67–71.9 years), and ‘2’ indicates the highest ages ($72 years).
doi:10.1371/journal.pone.0106521.g003
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In order to evaluate whether IL-6 levels were related to
processing speed, we conducted an additional analysis in which IL-
6 served as a primary predictor (including both the main effect and
the interaction term), and the processing speed score served as the
dependent variable.
Exploratory Analyses. Two exploratory analyses were
conducted. Given the strong association between processing speed
and white matter [18], we investigated whether CC FA accounted
for the association between IL-6 levels and processing speed using
a linear regression analysis.
For the second exploratory analysis, we evaluated whether IL-6
was related to corpus callosum volume, in addition to FA values,
using a linear regression analysis.
All linear analyses were conducted using SAS (version 9.4).
Ridge regression was conducted based on a ridge regression
function implemented in the R project for statistical computing
(http://www.r-project.org).
Results
Covariate Selection
Lower FA of the CC was associated with: higher age, male
gender, history of hypertension, higher homocysteine levels, higher
BMI, and a history of ever smoking. Higher IL-6 levels were
associated with older age, history of hypertension, higher BMI,
and higher homocysteine levels. Education, diabetes (n = 4) and
past history of hypercholesterolemia were not related to IL-6 levels
or CC integrity. Thus, only age and gender (demographics);
history of hypertension and smoking, and BMI (vascular risk
factors); and homocysteine (vascular marker) were included in
models.
Whole Brain Analysis (Figure 1)
After controlling for demographic variables, higher IL-6 levels
were associated with significantly lower FA of the CC, predom-
inantly in the splenium and body regions (p= .01). Although
isolated, scattered voxels of the right middle corona radiata were
significantly associated with IL-6, no consistent pattern was noted
bilaterally, nor was the association observed in anterior/posterior
regions. No other regions were significantly (p#.01) positively or
inversely associated with IL-6.
ROI Regression Analyses (Figure 2, Figure 3)
Linear regression analyses indicated that the interaction
between age and IL-6 was significant for the splenium
[F(1,126) = 7.23; t =22.69; unstandardized beta =2.0006; 95%
CI=2.0011 to 2.0002; p= .008], body [F(1,126) = 9.56; t =2
3.09; unstandardized beta =2.0009; 95% CI=2.0015 to 2.0003
p= .002], and genu [F(1,126) = 8.62; t =22.94; unstandardized
beta =2.0009; 95% CI=2.0016 to 2.0003; p= .004] of the
corpus callosum, after controlling for all covariates. Main effects
for IL-6 and age were not significant. In terms of confound
vascular markers, male gender [F(1,126) = 4.49, p= .04] and
higher BMI were [F(1,126) = 5.78, p = .02] associated with lower
FA in the splenium, hypertension [F(1,126) = 3.66, p= .058] with
lower FA in the body, and BMI for lower FA in the genu
[F(1,126) = 7.92; p= .006).
We followed-up the previous analysis with a ridge regression
analysis; this permitted us to determine the robustness of our
results, given the noted association between our vascular markers
and IL-6. Ridge analyses evidenced comparable findings, with the
interaction between age and IL-6 significant for all three sections
of the CC (spenium: p= .002; body and genu: p= .001).
The aforementioned analyses suggest that a synergistic effect of
older age and higher IL-6 predicts lower white matter integrity in
the splenium, body, and genu of the CC. In order to further
describe the interaction between IL-6 (continuous variable) and
age (continuous variable), we plotted the magnitude of IL-6 effects
relative to selected age bins (i.e. 60–90 years), by 5 year increments
for the genu, body, and splenium of the CC. As shown in Figure 2,
the magnitude of IL-6 effects on the genu, body, and splenium
increases with age, thus demonstrating a synergistic effect of age
and IL-6 on white matter integrity.
In addition, to garner a better understanding of the direction-
ality of the relationship between age, IL-6 and white matter
integrity, we also plotted the association between IL-6 and white
matter integrity as a function of age tertiles (Lowest Tertile ‘0’,
67.0 years; Middle Tertile ‘1’ = 67.0–71.9 years; Highest Tertile
‘2’$72 years) for descriptive purposes. We employed tertiles in
order to maintain equal size groups while also viewing IL-6 effects
across the age span; notably, similar results were found when
dividing age into decades (e.g. 60’s, 70’s, 80’s). As shown in
Figure 3, individuals in higher age groups tended to display a
negative slope, with higher IL-6 levels yielding lower white matter
integrity. Notably, individuals at lower age ranges (i.e. lowest
tertile) evidence a different pattern, in which higher IL-6 levels
were related to relatively better integrity across all three white
matter regions.
Cognitive Analyses
An initial examination of the main effect of Il-6 levels on
processing speed indicated that higher levels of IL-6 were
associated with slower information processing speed [F(1,
146) = 3.99; t = 2.00; unstandardized beta = 0.1414; 95%
CI= 0.0016 to 0.2813; p= .0475). After controlling for demo-
graphic variables and vascular factors/blood markers, the
interaction between IL-6 levels and age was associated with
processing speed [F(1,125) = 4.90; t = 2.21; unstandardized be-
ta = .0255, SE= .01; 95% CI= .0027 to.0484; p= .03], suggesting
that at higher ages and higher IL-6 levels, processing speed is
slower. Main effects for age and IL-6 were not significant for the
final model (including all covariates), nor were other confound
covariates.
Exploratory Analyses
We assessed whether CC FA accounted for the association
between the IL-6-age interaction and speed. After controlling for
all covariates and CC FA, the overall interaction between IL-6 and
age was no longer a significant predictor of speed [F (1,
124) = 3.29, p= .07], although it remained a trend.
Finally, we also examined the association between IL-6 levels
and CC volume. All regions of the CC were related to IL-6 in the
aforementioned analyses, thus we focused on total volume. After
controlling for all covariates and intracranial volume, IL-6 levels
were not significantly related to total CC volume [F (1, 119) = .67,
p= .66].
Discussion
The current study suggests that while vascular markers may
influence the pernicious correlation between IL-6 levels and
corpus callosum integrity, older age robustly and independently
modulates this association. Specifically, the interaction between
age and IL-6 remains predictive of CC FA after controlling for
vascular risk factors/blood indices; these analyses suggest that the
reduction of CC integrity associated with IL-6 is larger at older
ages relative to that at younger ages. To our knowledge, this is the
Interleukin-6, Age, and Corpus Callosum Integrity
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first study to examine possible moderators of the relationship
between IL-6 levels and white matter integrity in older adults.
Results from this study add to a growing body of literature
suggesting that ‘typical’ aging is quite heterogeneous, and
propelled in part by a combination of metabolic [37] and
inflammatory factors [38] that may be amenable to future
therapies.
Our findings further suggest multi-factorial associations between
IL-6 levels, brain structure, and cognition that are modified by the
aging milieu. Importantly, the influential role of age in our study
highlights that a linear process may not adequately capture the
deleterious relationship between IL-6 levels and white matter
integrity. Older age has been extensively correlated with higher
levels of circulating inflammatory markers as well as a host of
changes in both innate and adaptive immune functioning [39,40];
while immunocompetence should not be considered a static
process, our study suggests that negative associations with white
matter may be conferred at higher levels of IL-6, and the
magnitude of this effect strengthens with older age. Thus, older
age combined with higher levels of IL-6 appears to yield greater
risk for lower white matter integrity. Interestingly, when plotting
the association between IL-6 and white matter integrity using
tertiles of age, IL-6 levels appeared to be positively related to white
matter at younger ages. Although we employed these scatterplots
to further visualize the interaction between our two continuous
variables, the age at which a deleterious association between IL-6
and white matter integrity manifests remains unclear; moreover,
the possibility of a different and even beneficial association
between IL-6 levels and brain health at younger ages should be
further explored. In order to fully explicate the association
between IL-6 and white matter integrity across the older adult
age span, further research is needed.
Consistent with our predictions, IL-6 was primarily associated
with CC FA in the whole brain analysis, suggesting that this
interhemispheric tract may be not only vulnerable to aging and
vascular processes, but also inflammation-associated alterations. In
addition, our appraisal of white matter volume yielded no
significant associations with IL-6 levels, indicating that these
findings are not driven solely by CC atrophy. This is consistent
with prior literature highlighting the role of diffusion metrics as an
early marker of white matter changes rather than solely a
downstream effect of volume loss [15,41]. Catalysts underlying
the aging process (e.g. cellular senescence) may play a pivotal role
in altering how and when risk factors extend negative effects [42];
however, longitudinal studies are critical to understanding these
potentially influential factors.
An additional goal of the study was to clarify whether vascular
factors solely accounted for the association between IL-6 and CC
FA. Higher BMI and a history of hypertension remained
predictive of CC FA in our study, but did not fully account for
the IL-6-white matter relationship. Notably, a pro-inflammatory
process by its very nature utilizes vascular mechanisms to reach
target cells and tissues; however, this does not necessarily imply
that its association with white matter integrity is due to vascular
damage. In line with this thinking, study analyses underscore that
pro-inflammatory processes relate to white matter integrity,
independent of traditional vascular conduits. Our results thereby
imply a more complicated picture, in which both vascular markers
and inflammatory markers may contribute to ongoing white
matter changes in typical aging. Non-vascular mechanisms by
which inflammation may directly relate to white matter integrity
or specific brain tissue remain unclear and cannot be determined
from the current observational study. Importantly, however, our
findings suggest that examining the association between inflam-
mation and brain structure in isolation may yield an incomplete
and inaccurate model that does not fully capture the influential
role of age in the process.
An important behavioral analog to the IL-6 narrative is that
individuals with higher IL-6 levels displayed markedly slower
information processing speed than those with lower IL-6. Similar
to the DTI findings, this association increased as a function of age.
Although processing speed was evaluated due to its strong link
with interhemispheric and fronto-parietal white matter [43], the
parallel relationship between IL-6 and both white matter and
cognition suggests a possibly more extensive and compelling role
for inflammation in cognitive aging.
The current study displays numerous strengths, including the
use of multimodal imaging and multiple indices of vascular risk. In
addition, we also employed ridge regression techniques to assess
the robustness of our interaction effects. Ridge regression alleviates
the negative effects of correlation among predictors on properties
of estimates; in our study, comparable findings using both methods
suggest that our results are quite robust. However, it is prudent to
highlight limitations. First, we employed a peripheral inflamma-
tory marker, which may not reflect the CNS environment.
Although basic science research suggests a link between peripheral
markers and CNS functioning [44], direct comparisons to CNS
levels cannot be made based on the current data. In addition, we
only employed one diffusion metric in our white matter analyses;
although we chose the most commonly used measure of white
matter integrity (fractional anisotropy), future studies should
examine associations with other metrics, including radial diffusiv-
ity and axial diffusivity. Finally, our study was cross-sectional in
nature and thus cannot address issues of causality. Longitudinal
studies are needed to provide a more definitive understanding of
not only the progression of inflammatory markers over time in
healthy older adults, but also the temporal associations between
inflammation and structural brain changes. While we have clearly
pitched a dynamic association between age, IL-6 levels, and white
matter integrity, the directionality of these relationships cannot be
gleaned from observational data. Thus, it is possible that the role
of IL-6 levels is ancillary to another primary process not measured
in the current study.
In conclusion, study findings demonstrate that the detrimental
association between IL-6 levels and corpus callosum white matter
integrity is moderated by age, and this relationship is independent
of traditional vascular risk factors and blood markers. This study
highlights the important, burgeoning role of immunological
processes in understanding cognitive aging trajectories.
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